US Stock MarketDetailed Quotes

TNGX Tango Therapeutics

Watchlist
  • 1.840
  • -0.060-3.16%
Close Mar 4 16:00 ET
198.92MMarket Cap-1.55P/E (TTM)

Tango Therapeutics Key Stats

Tango Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 7 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 6.487M--
--2025/Q1-- / 6.801M--
--2024/Q44.117M / 8.018M--
--2024/Q311.607M / 8.066M--
--2024/Q219.875M / 7.632M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 6.487M--
--2025/Q1-- / 6.801M--
--2024/Q44.117M / 8.018M--
--2024/Q311.607M / 8.066M--
--2024/Q219.875M / 7.632M--

Unlock Free Earnings Estimates

Tango Therapeutics Earnings Reports

Read more

Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Mar 3, 2025

Buy

  • Buy

    100.00%
  • Hold

    0.00%
  • Sell

    0.00%

Price Target

No Data